"This is Bristol-Myers Squibb's first discovery collaboration in China and is an example of the company's deepening commitment to the country," said Francis Cuss, M.D., senior vice president, Research."I strongly believe that future cooperation between Tsinghua University and Bristol-Myers Squibb will bring about further-reaching consequences to both organizations and I wish every success in this cooperation." "We are delighted to be working with Tsinghua University, a world-renowned and highly esteemed research-based academic institution with expertise in target identification and structural biology that will support the discovery of new medicines to fight serious diseases in China and around the world."
"On April 22, 1911, almost 101 years ago, Tsinghua University was founded. We have committed ourselves to working with the finest institutions and enterprises to jointly conduct cutting-edge research. In that spirit, Tsinghua University's School of Life Sciences is building a strategic partnership with Bristol-Myers Squibb," said Professor Kejun Kang, vice president of Tsinghua University. "I strongly believe that future cooperation between Tsinghua University and Bristol-Myers Squibb will bring about further-reaching consequences to both organizations and I wish every success in this cooperation."
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
About Tsinghua University
Founded in 1911, Tsinghua University is a world-renowned university. With the motto of "Self-Discipline and Social Commitment" and the spirit of "Actions Speak Louder than Words," Tsinghua University is dedicated to the well-being of Chinese society and to world development.